| DUXAP8 | hepatocellular carcinoma | qRT-PCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32022476 | 2020 |
| DUXAP8 | bladder cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 29917188 | 2018 |
| DUXAP8 | esophageal squamous cell carcinoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 29771416 | 2018 |
| DUXAP8 | oral cancer | qPCR, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 32304409 | 2020 |
| DUXAP8 | non small cell lung cancer | qPCR, Western blot, Luciferase reporter assay etc | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✘ | ✘ | 32271433 | 2020 |
| DUXAP8 | colorectal cancer | qPCR, RIP etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31786844 | 2019 |
| DUXAP8 | hepatocellular carcinoma | qRT-PCR , RIP etc. | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31571902 | 2019 |
| DUXAP8 | pancreatic cancer | qPCR, RIP, Western blot, Other | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 30367681 | 2018 |
| DUXAP8 | renal cell carcinoma | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 30317248 | 2018 |
| DUXAP8 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 31364111 | 2019 |
| DUXAP8 | renal cell carcinoma | Microarray, qPCR, RNAi etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 29152119 | 2017 |
| DUXAP8 | non small cell lung cancer | qPCR, RNAi, western blot | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 28131418 | 2017 |
| DUXAP8 | gastric cancer | qPCR, RNAi, Western blot, Cell proliferation assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 27507049 | 2016 |
| DUXAP8 | gastric cancer | qPCR, Western blot, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 28881724 | 2016 |
| DUXAP8 | esophageal cancer | qPCR, western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 29771416 | 2018 |
| DUXAP8 | esophageal cancer | qPCR, etc. | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 29926523 | 2018 |
| DUXAP8 | bladder cancer | qPCR, Western blot, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 29917188 | 2018 |
| DUXAP8 | Osteosarcoma | Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 33982765 | 2021 |
| DUXAP8 | Triple negative breast cancer | CCK-8 assay;qRT-PCR;Flow Cytometry assay;Rescue assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 33683171 | 2021 |
| DUXAP8 | Papillary thyroid cancer | Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 33522355 | 2021 |
| DUXAP8 | Hepatocellular carcinoma | RNA immunoprecipitation;Western blot;luciferase assay;RNA immunoprecipitation;RNA pull-down; | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 33313387 | 2020 |
| DUXAP8 | Papillary thyroid cancer | qPCR;RT-qPCR;RIP assay;Western blot;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 33760128 | 2021 |